Compass Therapeutics Inc. Annual Shareholders Meeting Transcript
Good morning. Welcome to the 2026 Annual Meeting of Stockholders of Compass Therapeutics, Inc. I'm Thomas Schuetz, the Chief Executive Officer and Vice Chairman of the Board of Directors. We're excited to be hosting our meeting virtually again this year to reach a greater number of our stockholders.
As is our custom, we will conduct the business portion of the meeting first and answer any questions at the end. At this time, I call the meeting to order. There are four items of business for this morning's meeting. Each of which is described in our notice and proxy statement mailed on or about April 29, 2026.
One, the election of two Class 3 Directors. Two, the ratification of the appointment of the company's independent registered public accounting firm. Three, the approval on a non-binding advisory basis of the compensation of our named Executive Officers. And four, the approval on a non-binding advisory basis of the frequency of the holding of future advisory votes on the compensation of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
